Cargando…

BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer

SIMPLE SUMMARY: The combination of CDK4/6 inhibitors + fulvestrant or tamoxifen effectively prolongs survival in patients with estrogen receptor-positive (ER(+)) breast cancer. However, in the case of residual and metastatic disease, morbidity and mortality are virtually inevitable. Recently, the ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elshazly, Ahmed M., Sinanian, Melanie M., Neely, Victoria, Chakraborty, Eesha, Alshehri, Muruj A., McGrath, Michael K., Harada, Hisashi, Schoenlein, Patricia V., Gewirtz, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452571/ https://www.ncbi.nlm.nih.gov/pubmed/37627092 http://dx.doi.org/10.3390/cancers15164066

Ejemplares similares

Therapeutic Potential for Targeting Autophagy in ER+ Breast Cancer
por: Finnegan, Ryan M., et al.
Publicado: (2022)

The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells
por: Softah, Abrar, et al.
Publicado: (2023)

An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer
por: Elshazly, Ahmed M., et al.
Publicado: (2022)

Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells—Implications for Autophagy Modulation as a Therapeutic Strategy
por: Xu, Jingwen, et al.
Publicado: (2022)

The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer
por: Finnegan, Ryan M., et al.
Publicado: (2023)

Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription
por: Nagarajan, Sankari, et al.
Publicado: (2014)

Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
por: Segatto, Marco, et al.
Publicado: (2017)

Is autophagy induction by PARP inhibitors a target for therapeutic benefit?
por: ELSHAZLY, AHMED M., et al.
Publicado: (2022)

H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription
por: Nagarajan, Sankari, et al.
Publicado: (2015)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

Bromodomain-containing subunits BRD1, BRD2, and BRD13 are required for proper functioning of SWI/SNF complexes in Arabidopsis
por: Jarończyk, Kamila, et al.
Publicado: (2021)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

tBRD-1 and tBRD-2 regulate expression of genes necessary for spermatid differentiation
por: Theofel, Ina, et al.
Publicado: (2017)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

Supercharging BRD4 with NUT in carcinoma
por: Eagen, Kyle P., et al.
Publicado: (2021)

Emerging Roles of BRD7 in Pathophysiology
por: Park, Sang Won, et al.
Publicado: (2020)

BRD4 inhibitors block telomere elongation
por: Wang, Steven, et al.
Publicado: (2017)

Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2023)

Brd4‐Brd2 isoform switching coordinates pluripotent exit and Smad2‐dependent lineage specification
por: Fernandez‐Alonso, Rosalia, et al.
Publicado: (2017)

BRD4 inhibition for the treatment of pathological organ fibrosis
por: Stratton, Matthew S., et al.
Publicado: (2017)

A longitudinal population-based analysis of relationship status and mortality in KwaZulu-Natal, South Africa 2001–2011
por: Channon, Melanie, et al.
Publicado: (2016)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

Targeting BRD9 by I-BRD9 efficiently inhibits growth of acute myeloid leukemia cells
por: Zhou, Lixin, et al.
Publicado: (2021)

Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
por: Liu, Yi, et al.
Publicado: (2023)

BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021)

Molecular dynamics simulations data of six compounds F3J-BRD4/CBP, EX1-BRD4/CBP, and E2T-BRD4/CBP
por: Wu, Shiliang, et al.
Publicado: (2021)

BRD2 Compartmentalizes the Accessible Genome
por: Xie, Liangqi, et al.
Publicado: (2022)

Response to “Clinical recommendations for use of lidocaine lubricant during bowel care after spinal cord injury prolong care routines and worsen autonomic dysreflexia: results from a randomized clinical trial” – the authors reply
por: Lucci, Vera-Ellen M., et al.
Publicado: (2021)

Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations
por: Wang, Lifei, et al.
Publicado: (2022)

Cloning BRD4 long isoform into overexpression vectors for stable overexpression of BRD4-L in mammalian cells
por: Drumond-Bock, Ana Luiza, et al.
Publicado: (2022)

Improving Education and Standards for Cleft Care in the Developing World: The Partner Hospital Model
por: Purnell, Chad A., et al.
Publicado: (2015)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

TUNEL labeling with BrdUTP/anti-BrdUTP greatly underestimates the level of sperm DNA fragmentation in semen evaluation
por: Ribeiro, Sofia C., et al.
Publicado: (2017)

Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression
por: Dai, Jin, et al.
Publicado: (2019)

BRD4 as a Therapeutic Target in Pulmonary Diseases
por: Guo, Xia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ftkntov8s45ecpklm29l24v662